ArticleFrontiers in pharmacology2026

Bufothionine inhibits colorectal cancer progression via the STAT3/p53/SLC7A11 signaling axis.

Ruifang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.